ENTRY       D11230                      Drug
NAME        Crotedumab (USAN/INN)
FORMULA     C6518H10044N1732O2052S46
EXACT_MASS  146884.1989
MOL_WEIGHT  146974.8552
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS NYLMNWVRQA PGKGLEWLAN IQEDGIEKYY
            VDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCAREP SHYDILTGYD YYYGMDVWGQ
            GTTVTVSSAS TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSNN SGALTSGVHT
            FPAVLQSSGL YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP
            EFLGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR
            EEQFNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP
            PSQEEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV
            DKSRWQEGNV FSCSVMHEAL HNHYTQKSLS LSLGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQGIR NDLGWYQQKP GKAPKRLIYA ASSLQSGVPS
            RFSGSGSGTE FILTVSSLQP EDFATYYCLQ YNENPFTFGP GTKVDIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEEHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H142-L214, H155-H211, H234-H'234, H237-H'237, H269-H329, H375-H433, H'22-H'96, H'142-L'214, H'155-H'211, H'269-H'329, H'375-H'433, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antidiabetic
  TYPE      Monoclonal antibody
COMMENT     Treatment of diabetes
TARGET      GCGR [HSA:2642] [KO:K04583]
  PATHWAY   hsa04080(2642)  Neuroactive ligand-receptor interaction
            hsa04922(2642)  Glucagon signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GCGR
                 D11230  Crotedumab (USAN/INN)
DBLINKS     CAS: 1452387-69-7
            PubChem: 384585208
///
